SpyGlass Pharma, a late-stage biopharmaceutical company, today announced that the first patients have been randomized in two registrational Phase III clinical trials of its lead product candidate, the ...
Leaders of the D.S.M., the world’s most influential psychiatric manual, have been split for more than five years over whether ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback